First Synthesis of Ergotamine- 13 CD 3 and Ergotaminine- 13 CD 3 from Unlabeled Ergotamine.
Sven-Oliver HerterHajo HaaseMatthias KochPublished in: Toxins (2024)
Ergot alkaloids (EAs) formed by Claviceps fungi are one of the most common food contaminants worldwide, affecting cereals such as rye, wheat, and barley. To accurately determine the level of contamination and to monitor EAs maximum levels set by the European Union, the six most common EAs (so-called priority EAs) and their corresponding epimers are quantified using high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS). The quantification of EAs in complex food matrices without appropriate internal standards is challenging but currently carried out in the standard method EN 17425:2021 due to their commercial unavailability. To address the need for isotopically labeled EAs, we focus on two semi-synthetic approaches for the synthesis of these reference standards. Therefore, we investigate the feasibility of the N 6 -demethylation of native ergotamine to yield norergotamine, which can subsequently be remethylated with an isotopically labeled methylating reagent, such as iodomethane ( 13 CD 3 -I), to yield isotopically labeled ergotamine and its C 8 -epimer ergotaminine. Testing the isotopically labeled ergotamine/-inine against native ergotamine/-inine with HPLC coupled to high-resolution HR-MS/MS proved the structure of ergotamine- 13 CD 3 and ergotaminine- 13 CD 3 . Thus, for the first time, we can describe their synthesis from unlabeled, native ergotamine. Furthermore, this approach is promising as a universal way to synthesize other isotopically labeled EAs.
Keyphrases
- high performance liquid chromatography
- tandem mass spectrometry
- ms ms
- ultra high performance liquid chromatography
- simultaneous determination
- high resolution
- solid phase extraction
- mass spectrometry
- liquid chromatography
- pet imaging
- gas chromatography
- liquid chromatography tandem mass spectrometry
- risk assessment
- human health
- health risk